Real-world Evidence to Advance Knowledge in Pulmonary Hypertension: Status, Challenges, and Opportunities. A Consensus Statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working...

Overview

Journal Pulm Circ

Publisher Wiley

Specialty Pulmonary Medicine

Date 2023 Dec 25

PMID 38144948

Authors

Kellie Morland

Christian Gerges

Jean Elwing

Scott H Visovatti

Jason Weatherald

Kari R Gillmeyer

Sandeep Sahay

Stephen C Mathai

Athenais Boucly

Paul G Williams

Sivadasanpillai Harikrishnan

Evan P Minty

Lukas Hobohm

Arun Jose

Roberto Badagliacca

Edmund M T Lau

Zhi-Cheng Jing

Rebecca R Vanderpool

Charles Fauvel

Jose Leonidas Alves Jr

Geoff Strange

Tomas Pulido

Junyan Qian

Mengtao Li

Valentina Mercurio

Jason G E Zelt

Victor M Moles

Meghan M Cirulis

Sylvia M Nikkho

Raymond L Benza

C Gregory Elliott

Affiliations

Soon will be listed here.

Abstract

This manuscript on real-world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real-World Evidence Working Group. We aim to strengthen the research community's understanding of RWE in PH to facilitate clinical research advances and ultimately improve patient care. Herein, we review real-world data (RWD) sources, discuss challenges and opportunities when using RWD sources to study PH populations, and identify resources needed to support the generation of meaningful RWE for the global PH community.

Citing Articles

Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working....

Morland K, Gerges C, Elwing J, Visovatti S, Weatherald J, Gillmeyer K Pulm Circ. 2023; 13(4):e12317.

PMID: 38144948 PMC: 10739115. DOI: 10.1002/pul2.12317.

References

Trammell A, Shah A, Phillips L, Hart C . Mortality in US veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors. Pulm Circ. 2019; 9(1):2045894019825763. PMC: 6381440. DOI: 10.1177/2045894019825763. View

Arlett P, Kjaer J, Broich K, Cooke E . Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value. Clin Pharmacol Ther. 2021; 111(1):21-23. PMC: 9299492. DOI: 10.1002/cpt.2479. View

Keerie C, Tuck C, Milne G, Eldridge S, Wright N, Lewis S . Data sharing in clinical trials - practical guidance on anonymising trial datasets. Trials. 2018; 19(1):25. PMC: 5763739. DOI: 10.1186/s13063-017-2382-9. View

Tamura Y, Kumamaru H, Satoh T, Miyata H, Ogawa A, Tanabe N . Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension. Circ J. 2017; 82(1):275-282. DOI: 10.1253/circj.CJ-17-0139. View

Radegran G, Kjellstrom B, Ekmehag B, Larsen F, Rundqvist B, Blomquist S . Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014. Scand Cardiovasc J. 2016; 50(4):243-50. DOI: 10.1080/14017431.2016.1185532. View

Scott J, Garnett C, Kanwar M, Stockbridge N, Benza R . Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials. Am J Respir Crit Care Med. 2020; 203(6):726-736. PMC: 7958501. DOI: 10.1164/rccm.202002-0357OC. View

Harikrishnan S, Mani A, G S, M A, Menon J, G R . Pulmonary Hypertension Registry of Kerala, India (PRO-KERALA): One-year outcomes. Indian Heart J. 2021; 74(1):34-39. PMC: 8891004. DOI: 10.1016/j.ihj.2021.12.002. View

Schuler K, Hemnes A, Annis J, Farber-Eger E, Lowery B, Halliday S . An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record. Respir Res. 2022; 23(1):138. PMC: 9145474. DOI: 10.1186/s12931-022-02055-0. View

Sandoval Zarate J, Jerjes-Sanchez C, Ramirez-Rivera A, Pulido Zamudio T, Gutierrez-Fajardo P, Elizalde Gonzalez J . Mexican registry of pulmonary hypertension: REMEHIP. Arch Cardiol Mex. 2016; 87(1):13-17. DOI: 10.1016/j.acmx.2016.11.006. View

10.

Boucly A, Weatherald J, Savale L, Jais X, Cottin V, Prevot G . Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017; 50(2). DOI: 10.1183/13993003.00889-2017. View

11.

Thenappan T, Shah S, Rich S, Gomberg-Maitland M . A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007; 30(6):1103-10. DOI: 10.1183/09031936.00042107. View

12.

Chang K, Duval S, Badesch D, Bull T, Chakinala M, De Marco T . Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. J Am Heart Assoc. 2022; 11(9):e024969. PMC: 9238604. DOI: 10.1161/JAHA.121.024969. View

13.

Gillmeyer K, Nunez E, Rinne S, Qian S, Klings E, Wiener R . Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data. Chest. 2020; 159(5):1986-1994. PMC: 8129727. DOI: 10.1016/j.chest.2020.12.010. View

14.

Valverde A, Soares J, Viana K, Gomes B, Soares C, Souza R . Pulmonary arterial hypertension in Latin America: epidemiological data from local studies. BMC Pulm Med. 2018; 18(1):106. PMC: 6019295. DOI: 10.1186/s12890-018-0667-8. View

15.

Benza R, Miller D, Barst R, Badesch D, Frost A, McGoon M . An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012; 142(2):448-456. DOI: 10.1378/chest.11-1460. View

16.

DesJardin J, Kolaitis N, Kime N, Kronmal R, Benza R, Elwing J . Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry. J Heart Lung Transplant. 2020; 39(9):945-953. DOI: 10.1016/j.healun.2020.05.005. View

17.

Woldemariam M, Jimma W . Adoption of electronic health record systems to enhance the quality of healthcare in low-income countries: a systematic review. BMJ Health Care Inform. 2023; 30(1). PMC: 10277040. DOI: 10.1136/bmjhci-2022-100704. View

18.

Concato J, Corrigan-Curay J . Real-World Evidence - Where Are We Now?. N Engl J Med. 2022; 386(18):1680-1682. DOI: 10.1056/NEJMp2200089. View

19.

Crane G, Lim J, Gau C, Xie J, Chu L . The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations. Curr Med Res Opin. 2022; 38(9):1543-1551. DOI: 10.1080/03007995.2022.2096354. View

20.

Harikrishnan S, Sanjay G, Ashishkumar M, Menon J, Rajesh G, Kumar R . Pulmonary hypertension registry of Kerala, India (PRO-KERALA) - Clinical characteristics and practice patterns. Int J Cardiol. 2018; 265:212-217. DOI: 10.1016/j.ijcard.2018.02.036. View